Renal PhysiologyApril 5, 20265 min read

Q-Bank Breakdown: Renal blood flow autoregulation — Why Every Answer Choice Matters

Clinical vignette on Renal blood flow autoregulation. Explain correct answer, then systematically address each distractor. Tag: Renal > Renal Physiology.

Renal autoregulation questions feel “simple” until the answer choices start mixing afferent vs efferent, myogenic vs tubuloglomerular feedback, and neural/hormonal overrides. The trick is to treat every distractor like a mini–renal physiology concept check—because that’s exactly what Q-banks are doing.


Clinical vignette (Q-bank style)

A 27-year-old healthy man participates in a research study. His mean arterial pressure (MAP) is gradually increased from 85 mmHg to 105 mmHg using a low-dose vasopressor infusion. Despite this, his measured renal blood flow (RBF) and glomerular filtration rate (GFR) remain essentially unchanged over the next several minutes. Which mechanism most directly explains this finding?

A. Increased renin release leading to efferent arteriolar constriction
B. Myogenic constriction of the afferent arteriole in response to increased transmural pressure
C. Prostaglandin-mediated dilation of the afferent arteriole
D. Sympathetic (α1)–mediated constriction of the afferent arteriole
E. Decreased NaCl delivery to the macula densa causing afferent arteriolar dilation

Correct answer: B. Myogenic constriction of the afferent arteriole


First principles: what “autoregulation” is actually protecting

The kidneys are trying to keep RBF and GFR relatively constant over a broad MAP range (classically about 80–180 mmHg in healthy adults). Why?

  • Stabilizes GFR → steady solute delivery to tubules
  • Prevents pressure swings from causing glomerular injury
  • Keeps renal oxygen demand/supply more predictable

Autoregulation is primarily accomplished by:

  1. Myogenic response (fast, seconds)
  2. Tubuloglomerular feedback (TGF) via macula densa (slower, seconds to minutes)

Important: Autoregulation is intrinsic to the kidney (local arteriolar responses). It can be overridden by strong sympathetic tone or certain hormones in shock/hemorrhage.


Why B is correct: the myogenic response (the “stretch reflex” of arterioles)

When MAP rises, afferent arteriolar wall tension increases. Vascular smooth muscle responds by contracting.

  • Increased perfusion pressure → increased stretch of afferent arteriole
  • Stretch opens mechanosensitive channels → smooth muscle contraction
  • Afferent constriction increases renal vascular resistance → offsets the pressure increase
  • Result: RBF and GFR stay ~constant

This is the purest “autoregulation” answer because it requires no hormones, no macula densa signaling, and it occurs rapidly.

High-yield framing:

  • ↑ MAP → afferent constriction (myogenic) → stabilize RBF/GFR
  • ↓ MAP → afferent dilation (myogenic) → stabilize RBF/GFR

Rapid table: Afferent vs efferent changes (Step-friendly)

ChangeRBFGFRFiltration fraction (FF)
Afferent constriction~same or ↓
Afferent dilation~same
Efferent constriction (moderate)
Efferent constriction (severe)↓↓↑ or variable
Efferent dilation

Remember: Autoregulation primarily adjusts the afferent arteriole.


Systematically destroying the distractors (why each is wrong)

A. Increased renin → efferent constriction

Renin release (→ Ang II) is a RAAS response, typically activated when the kidney senses low perfusion pressure, low NaCl delivery, or β1 stimulation.

  • This stem describes increased MAP, not decreased effective circulating volume.
  • Ang II preferentially constricts the efferent arteriole, which tends to increase GFR (at least initially) and decrease RBF—not “keep both unchanged.”

When this choice would fit: hypovolemia/renal artery stenosis, where Ang II helps “prop up” GFR.


C. Prostaglandin-mediated afferent dilation

Prostaglandins (esp. PGE₂, PGI₂) are local vasodilators that help preserve renal perfusion when vasoconstrictors are high.

  • They matter most when the kidney is under vasoconstrictive threat (e.g., sympathetic tone, Ang II).
  • In a healthy patient with modest MAP increase and intact autoregulation, prostaglandins are not the primary explanation for stable RBF/GFR.

USMLE pearl: NSAIDs inhibit prostaglandins → afferent constriction → ↓ GFR (risk AKI), especially in volume depletion, CHF, cirrhosis.


D. Sympathetic (α1) afferent constriction

Sympathetic activation constricts arterioles (afferent > efferent) and also increases renin via β1.

  • If sympathetic tone were the dominant mechanism here, you’d expect decreased RBF and decreased GFR, not stable values.
  • Also, sympathetic control is extrinsic, not intrinsic autoregulation.

When this choice would fit: hemorrhage/shock → kidneys sacrifice GFR/RBF to maintain systemic perfusion.


E. Decreased NaCl delivery to macula densa → afferent dilation

This describes tubuloglomerular feedback, but it’s the wrong direction for this scenario.

Increased MAP typically increases GFR transiently, which increases tubular flow and increases NaCl delivery to the macula densa. The macula densa responds by:

  • releasing ATP/adenosine → afferent constriction
  • reducing renin release

So “decreased NaCl delivery” would occur when GFR is low (e.g., low perfusion), prompting afferent dilation and renin release to restore GFR.

High-yield TGF directionality:

  • ↑ NaCl at macula densa → afferent constriction + ↓ renin
  • ↓ NaCl at macula densa → afferent dilation + ↑ renin

How to recognize the tested concept in 5 seconds

Look for these clues:

Autoregulation is likely when:

  • Patient is otherwise stable
  • MAP changes modestly (within ~80–180 mmHg)
  • Question says RBF and GFR remain constant
  • Time frame is seconds to minutes

Autoregulation is not likely when:

  • Shock/hemorrhage/sepsis picture → sympathetic override
  • Drugs interfering with local mediators (NSAIDs, ACEi/ARBs)
  • Renal artery stenosis → RAAS dominates

“Why every answer choice matters” — classic Step drug/phys tie-ins

NSAIDs (block prostaglandins)

  • Lose afferent dilation buffer → afferent constriction
  • ↓ RBF, ↓ GFR → AKI risk

ACE inhibitors / ARBs (block Ang II)

  • Lose efferent constriction → efferent dilation
  • ↓ glomerular capillary hydrostatic pressure → ↓ GFR
  • Dangerous in bilateral renal artery stenosis (or stenosis of a solitary kidney)

Volume depletion states (CHF, cirrhosis, nephrotic syndrome)

  • Effective arterial blood volume low → kidneys rely on:
    • Prostaglandins to keep afferent open
    • Ang II to keep efferent tight
  • Combine diuretics + ACEi/ARB + NSAID = “triple whammy” for AKI

Quick recap (what you should walk away with)

  • Autoregulation keeps RBF and GFR stable across MAP changes (≈80–180 mmHg).
  • The most direct mechanism for an acute rise in MAP with stable RBF/GFR is myogenic afferent constriction.
  • TGF also contributes: ↑NaCl at macula densa → afferent constriction, ↓renin.
  • Distractors often test who constricts (afferent vs efferent) and which mediator (PGs, RAAS, sympathetic)—and whether that would stabilize or shift GFR/RBF.